SOD2 deficient erythroid cells up-regulate transferrin receptor and down-regulate mitochondrial biogenesis and metabolism. (73/161)

 (+info)

Refractory anemia with ring sideroblasts associated with marked thrombocytosis: a mixed group exhibiting a spectrum of morphologic findings. (74/161)

 (+info)

Missense SLC25A38 variations play an important role in autosomal recessive inherited sideroblastic anemia. (75/161)

 (+info)

ALAS2 acts as a modifier gene in patients with congenital erythropoietic porphyria. (76/161)

 (+info)

SF3B1 mutations are prevalent in myelodysplastic syndromes with ring sideroblasts but do not hold independent prognostic value. (77/161)

 (+info)

Congenital sideroblastic anemias: iron and heme lost in mitochondrial translation. (78/161)

 (+info)

Biogenesis of iron-sulfur clusters in mammalian cells: new insights and relevance to human disease. (79/161)

 (+info)

Pearson's marrow-pancreas syndrome. A multisystem mitochondrial disorder in infancy. (80/161)

Pearson's marrow-pancreas syndrome (McKusick No. 26056) is a fatal disorder of hitherto unknown etiology involving the hematopoietic system, exocrine pancreas, liver, and kidneys. The observation of high lactate/pyruvate molar ratios in plasma and abnormal oxidative phosphorylation in lymphocytes led us to postulate that Pearson's syndrome belongs to the group of mitochondrial cytopathies. Since rearrangements of the mitochondrial genome between direct DNA repeats were consistently found in all tissues tested, our results show that this disease is in fact a multisystem mitochondrial disorder, as suggested by the clinical course of the patients. Based on these observations, we would suggest giving consideration to the hypothesis of a defect of oxidative phosphorylation in elucidating the origin of other syndromes, especially those associated with an abnormal oxidoreduction status in plasma.  (+info)